Table 2.
Characteristics of studies that analyzed the effects of surgical interventions to reduce weight on renal parameters
Reference | Type of Study | Baseline Kidney Disease | Preintervention BMI (kg/m2) or Body Weight (kg) | Comorbidities | No. of Patients | Intervention | Follow-up | Renal Outcomes | Nonrenal Outcomesa |
---|---|---|---|---|---|---|---|---|---|
Agrawal et al. (30), 2008 | Retrospective | Microalbuminuria | 49.1 ± 7.4 | Diabetes, metabolic syndrome | 94 | Roux-en-Y gastric bypass | 12 mo | Urine albumin-creatinine ratio | Hs-CRP, BP, diabetes |
Alexander and Goodman et al. (31), 2007 | Prospective cohort | ESRD, CKD | NA | NA | 45 (total) 23 (CKD) 22 (dialysis) |
Roux-en-Y gastric bypass | Up to 13 yr | Serum creatinine | NA |
Brochner-Mortensen et al. (32), 1980 | Prospective cohort | Glomerular hyperfiltration | 136.4 kg | None | 8 | End-to-side jejunoileostomy | 1 yr | Serum creatinine, GFR (using EDTA) | Extracellular volume |
Chagnac et al. (29), 2003 | Prospective cohort | Glomerular hyperfiltration | 48 ± 2.4 | Hypertension | 17 | Gastroplasty | 12 to 17 mo | GFR (using inulin clearance), renal plasma flow, filtration fraction, albuminuria | Oral glucose tolerance test, BP |
Navarro-Diaz et al. (27), 2006b | Prospective cohort | Glomerular hyperfiltration | 53.6 ± 9.6 | CAD, hypertension | 85 | Gastroplasty | 24 mo | 24-h urinary creatinine clearance, proteinuria | BP |
Palomar et al. (26), 2005 | Prospective cohort | Microalbuminuria and overt proteinuria | 46.9 ± 6.3 | Hypertension, diabetes, obstructive sleep apnea | 35 | Biliopancreatic diversion | 12 mo | Proteinuria, nephrolithiasis | Lipid profile, BP, hematologic parameters |
Serra et al. (28), 2006b | Prospective cohort | Microalbuminuria | 53.3 ± 9.6 | Hypertension | 70 | Roux-en-Y gastric bypass | 12 mo | 24-h urinary creatinine clearance, proteinuria | Leptin, adiponectin, lipid profile, insulin level, BP |
CAD, coronary artery disease; hs-CRP, high-sensitivity C-reactive protein.
All studies measured BMI and change in weight over time.
Same set of patients were included and different outcome measures were reported, and only study with longer duration of follow-up was used for analysis.